Evidence map›Paper›PMID 31234302›Full record

ReviewPathogens (Basel, Switzerland)2019

How Many Mammalian Reovirus Proteins are involved in the Control of the Interferon Response?

Delphine Lanoie, Simon Boudreault, Martin Bisaillon, Guy Lemay

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Dissemination ofPathogens (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Delphine LanoieDépartement de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, QC H3C 3J7, Canada. delphine.lanoie@umontreal.ca.
Simon BoudreaultDépartement de biochimie, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada. simon.boudreault@usherbrooke.ca.
Martin BisaillonDépartement de biochimie, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada. martin.bisaillon@usherbrooke.ca.
Guy LemayDépartement de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, QC H3C 3J7, Canada. guy.lemay@umontreal.ca.ORCID 0000-0002-0402-1285
Université de Montréal · CAUniversité de Sherbrooke · CA

Funding

Natural Sciences and Engineering Research Council of Canada RGPIN/03736-2017Natural Sciences and Engineering Research Council of Canada RGPIN-2016-03916
6 · The paper itself

Abstract

As with most viruses, mammalian reovirus can be recognized and attacked by the host-cell interferon response network. Similarly, many viruses have developed resistance mechanisms to counteract the host-cell response at different points of this response. Reflecting the complexity of the interferon signaling pathways as well as the resulting antiviral response, viruses can-and often have-evolved many determinants to interfere with this innate immune response and allow viral replication. In the last few years, it has been evidenced that mammalian reovirus encodes many different determinants that are involved in regulating the induction of the interferon response or in interfering with the action of interferon-stimulated gene products. In this brief review, we present our current understanding of the different reovirus proteins known to be involved, introduce their postulated modes of action, and raise current questions that may lead to further investigations.

Indexed as

interferonreovirusviral proteinsvirus

Identifiers

PMID31234302
PMCPMC6631787
OpenAlexW2951086303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.